{"id":"W4392210732","doi":"10.2196/54178","title":"Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes","year":2024,"lang":"en","type":"article","venue":"JMIR Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Universität Zürich; Swiss Tumor Institute","keywords":"Biosimilar; Trastuzumab; Medicine; Observational study; Breast cancer; Clinical trial; Human Epidermal Growth Factor Receptor 2; Oncology; Internal medicine; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000914986,0.0002046551,0.0007553838,0.0001001986,0.00008189005,0.00001529708,0.0003055249,0.00005297269,0.00002645165],"category_scores_gemma":[0.000161051,0.00009548671,0.0001161309,0.0008355454,0.0002561071,0.00006382635,0.00006079276,0.0002085394,2.074541e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006745557,"about_ca_system_score_gemma":0.00145549,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.008419657,"about_ca_topic_score_gemma":0.01965748,"domain_scores_codex":[0.9970685,0.0001014253,0.001343104,0.0004619134,0.0007186469,0.0003063672],"domain_scores_gemma":[0.9966087,0.0006855884,0.001292447,0.0009198085,0.0004636265,0.00002988242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001291648,0.0009602349,0.9741167,0.0007730101,0.0009939881,0.000003041757,0.009747616,0.0001342779,0.0007744883,0.00005939657,0.0004079667,0.01073758],"study_design_scores_gemma":[0.002233895,0.001940007,0.9811729,0.0009469166,0.0005214148,0.000007708109,0.005347797,0.003262897,0.003519874,0.00003810758,0.0009118949,0.00009665307],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878816,0.001475401,0.00001368294,0.002253492,0.00007602638,0.00779009,0.000383244,0.00002008074,0.0001063908],"genre_scores_gemma":[0.9961058,0.0002245908,0.00008472549,0.00002519784,0.00006354106,0.003246841,0.00003824939,0.00003577786,0.0001752667],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01123783,"threshold_uncertainty_score":0.9982312,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1278437417289211,"score_gpt":0.4706072347069483,"score_spread":0.3427634929780272,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}